Archive for January, 2018

Our 2018 PBCC Research Grant Winners are…

Posted By on January 23rd, 2018 at 8:30 am | 0 comments.

Some of the best and brightest minds in breast cancer research are working right here in our state. Without funding for their projects, our scientists cannot move forward. That’s where the PBCC’s Research Grants Initiative comes in. In 2018, we are proud to award $200,000 to the following breast cancer researchers:

David Cormode, PhD
Associate Professor of Biology
Perelman School of Medicine
University of Pennsylvania

Sean Knecht, PhD
Instructor
School of Engineering, Technology and Professional Programs
Penn State University

Steffi Oesterreich, PhD
Professor & Vice Chair
Precision and Translational Pharmacology
Magee-Womens Research Institute at the University of Pittsburgh Medical Center

Wendie Berg, PhD, MD, FACR
Professor of Radiology
University of Pittsburgh School of Medicine
Magee-Womens Hospital of the University of Pittsburgh Medical Center

Our 2018 research grant recipients are studying better detection for breast cancer, genetics and breast density. The PA Breast Cancer Coalition remains focused on supporting scientists working to find the cause of and cure for breast cancer. Want to bring us closer to that cure? Donate your state income tax refund to the PBCC on Line 32 and every penny will support Pennsylvania breast cancer researchers!

FDA Approves 1st Drug for Advanced Breast Cancer Caused by BRCA1, BRCA2 Mutations

Posted By on January 21st, 2018 at 9:10 am | 0 comments.

Previous PBCC Research Award winner Dr. Susan Domchek co-led study

It’s a breakthrough for advanced breast cancer patients with BRCA1 or BRCA2 gene mutations. The U.S. Food and Drug Administration last week approved its first treatment for advanced breast cancer caused by the inherited mutations. The drug, Lynparza (olaparib tablets), was previously approved to treat advanced ovarian cancer caused by mutations of BRCA1 or BRCA2.

University of Pennsylvania researcher and previous PBCC Research Award winner Dr. Susan Domchek co-led the study that led to the drug’s approval for breast cancer. Dr. Domchek calls the drug’s approval a significant advance for those women with triple-negative breast cancer and a BRCA mutation.

FREE Bras for Medicare Recipients Facing Breast Cancer

Posted By on January 20th, 2018 at 10:27 am | 0 comments.

Did you know? Medicare covers post-mastectomy or lumpectomy bras. Doctors may order FREE bras (up to $30 each) for breast cancer survivors who have had a mastectomy or lumpectomy and are covered under Medicare. Medicare covers the first $30 of each bra and the woman is responsible for any costs above that amount. Survivors who have had reconstructive surgery are also eligible for free bras. More information to come in future PBCC publications!

Lancaster City Police K-9 Unit Takes a “Bite Out of Breast Cancer”

Posted By on January 16th, 2018 at 2:26 pm | 0 comments.

Taking a Bite Out of Cancer, the Lancaster City Police K-9 and Mounted Units held a special fundraiser for the PA Breast Cancer Coalition in October 2017. Officers sold pink t-shirts in honor of breast cancer awareness month, with a portion of proceeds benefiting the PBCC’s life-saving work throughout the state. The first annual campaign was a doggone success, with a total of $562 going to our programs and services for breast cancer survivors in PA! The PBCC staff was thrilled when the K-9 unit stopped by our office to deliver the donation with dogs in tow! Thank you to Officers Alexander, Reppert, Hatfield and Bradley for bringing K-9s Axel, Stryker, Zoltan and Wodan to our headquarters in Lebanon for this presentation, and to Sargent Michael Gerace for spearheading this unique campaign! The PBCC is honored to be the recipients of this meaningful gift.